Avanos Medical (AVNS) Enterprise Value (2014 - 2026)

Avanos Medical has disclosed Enterprise Value across 13 years of filings, most recently posting $588.3 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 4.02% year-over-year to $588.3 million; the TTM figure through Mar 2026 stood at $588.3 million (up 4.02% YoY), while the FY2025 annual figure was $431.9 million, down 30.79% from the prior year.
• Enterprise Value came in at $588.3 million for Q1 2026 at Avanos Medical, up from $431.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $1.5 billion in Q1 2022 to a low of $431.9 million in Q4 2025.
• Average Enterprise Value over 5 years is $864.8 million, with a median of $841.4 million recorded in 2024.
• Year-over-year, Enterprise Value increased 22.09% in 2024 and slumped 54.09% in 2025.
• Over 5 years, Enterprise Value stood at $1.1 billion in 2022, then decreased by 16.21% to $948.0 million in 2023, then slumped by 34.17% to $624.0 million in 2024, then sank by 30.79% to $431.9 million in 2025, then jumped by 36.21% to $588.3 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $588.3 million in Q1 2026, $431.9 million in Q4 2025, and $466.1 million in Q3 2025.